Your search
Results 2 resources
-
Background: Appropriate use of antimicrobials for hematologic malignancy, hematopoietic stem cell transplant recipients, and other cellular therapies is vital, with infection causing significant morbidity and mortality in this unique population of immunocompromised hosts. However, often in this population the choice and management of antimicrobial therapy is complex. When selecting an antimicrobial agent, key considerations include the need for dose adjustments due to renal or hepatic...
-
T he first consensus guideline for therapeutic monitoring of vancomycin in adult patients was published in 2009. A committee representing 3 organizations (the American Society for Health-System Pharmacists [ASHP], Infectious Diseases Society of America [IDSA], and Society for Infectious Diseases Pharmacists [SIDP]) searched and reviewed all relevant peer-reviewed data on vancomycin as it related to in vitro and in vivo pharmacokinetic and pharmacodynamic (PK/PD) characteristics, including...
Filter by our tag
GUIDELINES
- IDSA Guidelines (1)
CORE CURRICULUM
DRUGS AND THERAPIES
- Antibiotics
- Antifungals (1)
- Antivirals (1)
- Stewardship (1)
HEME-ONC AND CELLULAR THERAPIES
- CAR-T (1)
- Heme-onc prophylaxis (1)
- Neutropenia (1)